Prof. Alexander Gutfraind
Prof. Alexander Gutfraind
Loyola University Chicago
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Operational resilience: concepts, design and analysis
AA Ganin, E Massaro, A Gutfraind, N Steen, JM Keisler, A Kott, ...
Scientific reports 6 (1), 1-12, 2016
Understanding terrorist organizations with a dynamic model
A Gutfraind
Studies in Conflict & Terrorism 32 (1), 45-59, 2009
Optimizing topological cascade resilience based on the structure of terrorist networks
A Gutfraind
PloS one 5 (11), e13448, 2010
Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection
A Gutfraind, AP Galvani, LA Meyers
JAMA pediatrics 169 (4), 341-348, 2015
Multiscale network generation
A Gutfraind, I Safro, LA Meyers
2015 18th international conference on information fusion (fusion), 158-165, 2015
Optimal interdiction of unreactive Markovian evaders
A Gutfraind, A Hagberg, F Pan
Integration of AI and OR Techniques in Constraint Programming for …, 2009
Mathematical modeling of hepatitis C prevalence reduction with antiviral treatment scale-up in persons who inject drugs in metropolitan Chicago
D Echevarria, A Gutfraind, B Boodram, M Major, S Del Valle, SJ Cotler, ...
PloS one 10 (8), e0135901, 2015
Lanchester Theory and the Fate of Armed Revolts
MP Atkinson, A Gutfraind, M Kress
Arxiv preprint arXiv:1106.4358, 2011
Optimizing network topology for cascade resilience
A Gutfraind
Handbook of Optimization in Complex Networks: Communication and Social …, 2011
Indication of Outreach Options for Healthcare Facility to Facilitate Patient Actions
A McElhinney, A Gutfraind, N Bowers
US Patent App. 14/836,652, 2017
High-risk geographic mobility patterns among young urban and suburban persons who inject drugs and their injection network members
B Boodram, AL Hotton, L Shekhtman, A Gutfraind, H Dahari
Journal of Urban Health 95 (1), 71-82, 2018
Agent-based model forecasts aging of the population of people who inject drugs in metropolitan Chicago and changing prevalence of hepatitis C infections
A Gutfraind, B Boodram, N Prachand, A Hailegiorgis, H Dahari, ME Major
PloS one 10 (9), e0137993, 2015
Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia
A Gutfraind, LA Meyers
The Journal of infectious diseases 211 (8), 1262-1267, 2015
Risk analysis beyond vulnerability and resilience–characterizing the defensibility of critical systems
V Bier, A Gutfraind
European Journal of Operational Research 276 (2), 626-636, 2019
How do terrorist cells self-assemble: Insights from an agent-based model of radicalization
M Genkin, A Gutfraind
Available at SSRN 1031521, 2011
A graph database framework for covert network analysis: An application to the Islamic State network in Europe
A Gutfraind, M Genkin
Social Networks 51, 178-188, 2017
Optimizing distribution of pandemic influenza antiviral drugs
B Singh, HC Huang, DP Morton, GP Johnson, A Gutfraind, AP Galvani, ...
Emerging infectious diseases 21 (2), 251, 2015
Generating realistic scaled complex networks
CL Staudt, M Hamann, A Gutfraind, I Safro, H Meyerhenke
Applied Network Science 2, 1-29, 2017
Generating scaled replicas of real-world complex networks
CL Staudt, M Hamann, I Safro, A Gutfraind, H Meyerhenke
Complex Networks & Their Applications V: Proceedings of the 5th …, 2017
Interdiction of a Markovian Evader
A Gutfraind, AA Hagberg, D Izraelevitz, F Pan
Arxiv preprint arXiv:1009.0556, 2010
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20